Browse result page of TopicalPdb


Please click on the ID to see detailed information about each entry.

The total number entries retrieved from this search are
IDSequenceNameNature of peptide or cargoAssayTissue permeabilityTissue SamplePUBMED ID
1002AAPVAAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=0.46 μg/cm2/h, Permeability coefficient=1.50×10−4Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1003AAPVC6(D)-Laa-AAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=2.29 μg/cm2/h, Permeability coefficient=7.6×10−4 Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1004AAPVC6(L)-Laa- AAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=0.50 μg/cm2/h, Permeability coefficient=1.6×10−4 Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1005AAPVC8(D,L)-Laa-AAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=10.08 μg/cm2/h, Permeability coefficient= 3.3×10−3 Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1006AAPVC8(D)-Laa-AAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=7.42 μg/cm2/h, Permeability coefficient=1.90×10−2 Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1007AAPVC8(L)-Laa-AAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=1.37 μg/cm2/h, Permeability coefficient=4.50×10−4 Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1008AAPVC10(D,L)-Laa-AAPVIt fits the P-P1 subsites of elastase and inhibits HNE competitivelyFranz diffusion cell, HPLCEpidermal flux=8.92 μg/cm2/h, Permeability coefficient=2.9×10−3 Kp(cm/h)Human epidermal membranes were obtained by heat separation of whole skin24842663
1009RRRRRRRRRRRLILV
LLAI
11R-No. 10Melanogenesis inhibitory peptideConfocal microscopeWhen TMR-11R was topically applied for 24 h, the signals were only observed on the surface of the skin. In contrast, 12 h later, strong signals were detected showing that TMR-11R had arrived at the skin basal layer. Moreover, 24 and 48 hours later, the signals had spread out more and were stronger in both epidermis and dermisSkin from the back of a brown guinea pig24602570
1010GKRRR4 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 25.16 ± 2.31 , Q48 (mg) 1167.05 ± 50.10 Drug content in skin (mg/cm2) 146 ± 6.44 Human epidermal skin24134794
1011GKRRR4 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 43.74 ± 4.15 , Q48(mg) 2064.72 ± 100.05 Drug content in skin (mg/cm2) 180 ± 8.23Human epidermal skin24134794
1012GKRRR4 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 57.66 ± 4.83 , Q48(mg) 2706.53 ± 123.60, Drug content in skin (mg/cm2) 204 ± 8.41 Human epidermal skin24134794
1013GKKKRRRRR8 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) ± 4.83 , Q48(mg) 2706.53 ± 123.60, Drug content in skin (mg/cm2) 204 ± 8.41 Human epidermal skin24134794
1014GKKKRRRRR8 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 57.66 ± 4.83 , Q48(mg) 2706.53 ± 123.60, Drug content in skin (mg/cm2) 204 ± 8.41 Human epidermal skin24134794
1015GKKKRRRRR8 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 78.07 ± 7.52, Q48 (mg) 3666.44 ± 162.70 Drug content in skin (mg/cm2) 378± 15.11Human epidermal skin24134794
1016GKKKKKKKRRRRRRRRR16 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 21.43 ± 1.32 , Q48 (mg) 856.29 ± 39.50 Drug content in skin (mg/cm2) 151 ± 4.64 Human epidermal skin24134794
1017GKKKKKKKRRRRRRRRR16 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 23.46 ± 2.04 , Q48 (mg) 1106.03 ± 53.80 Drug content in skin (mg/cm2) 155 ± 4.85 Human epidermal skin24134794
1018GKKKKKKKRRRRRRRRR16 (arginine-terminated peptide dendrimers)Peptide dendrimers are wedge-like molecules comprising an amino acid branching core that is most typically decorated with various basic amino acids (e.g. Lys, His, Arg) on their head groupsFranz diffusion cellFlux (mg/cm2/h) 27.16 ± 2.65, Q48 (mg) 1256.61 ± 55.70, Drug content in skin (mg/cm2) 156 ± 6.26 Human epidermal skin24134794
1019KETWWETWWTEWSQP
KKKRKV
Pep-1Cell penetrating peptideIn vivo imagingSignificant permeability of the peptide can be seen in in vivo imagesMouse skin cells23601371
1023GRKKRRQRRRPPQRKCTatCell penetrating peptideVertical Franz diffusion cellTP could not pass through the skin due to the charge repulsion effect between the negative charge of the TP and the negative charge of the skinAbdominal skin of Sprague–Dawley rats23311648
1024GRKKRRQRRRPPQRKCTatCell penetrating peptideVertical Franz diffusion cellCumulative amounts0.10± 0.01 µg/cm2 and fluxes 0.60 ± 0.06 µg/cm2·hAcceptor compartment of Franz diffusion cell/Abdominal skin of Sprague–Dawley rats23311648
1025GRKKRRQRRRPPQRKCTatCell penetrating peptideVertical Franz diffusion cellCumulative amounts 0.31 ± 0.04 µg/cm2 and fluxes 1.86 ± 0.24 µg/cm2·hAbdominal skin of Sprague–Dawley rats23311648
1026GRKKRRQRRRPPQRKCTatCell penetrating peptideVertical Franz diffusion cellCumulative amounts 1.02 ± 0.05 µg/cm2 and fluxes 6.13± 0.28 µg/cm2·hAcceptor compartment of Franz diffusion cell/Abdominal skin of Sprague–Dawley rats23311648
1027GRKKRRQRRRPPQRKCTatCell penetrating peptideVertical Franz diffusion cellCumulative amounts 4.29 ± 0.40 µg/cm2 and fluxes 25.73 ± 2.40 µg/cm2·hAbdominal skin of Sprague–Dawley rats23311648
1028β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC~0.5% of applied doseStratum corneum of human breast skin22890441
1029β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC>0.5% of applied doseStratum corneum of human breast skin22890441
1030β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC>1% of applied doseStratum corneum of human breast skin22890441
1031β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC<0.5% of applied doseStratum corneum of human breast skin22890441
1032β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC<0.5% of applied doseStratum corneum of human breast skin22890441
1033β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC>1.5% of applied doseEpidermis of human breast skin22890441
1034β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC~2% of applied doseEpidermis of human breast skin22890441
1035β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC<4% of applied doseEpidermis of human breast skin22890441
1036β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC~0.5% of applied doseEpidermis of human breast skin22890441
1037β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC<1% of applied doseEpidermis of human breast skin22890441
1038β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC>8% of applied doseDermis of human breast skin22890441
1039β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC<4% of applied doseDermis of human breast skin22890441
1040β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC<18% of applied doseDermis of human breast skin22890441
1041β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC~3% of applied doseDermis of human breast skin22890441
1042β-Ala-HL -carnosineAntioxidantFranz diffusion cell, HPLC>8% of applied doseDermis of human breast skin22890441
1043β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC>5% of applied doseStratum corneum of human breast skin22890441
1044β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~6% of applied doseStratum corneum of human breast skin22890441
1045β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~1.5% of applied doseStratum corneum of human breast skin22890441
1046β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~5% of applied doseStratum corneum of human breast skin22890441
1047β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~3% of applied doseStratum corneum of human breast skin22890441
1048β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~2% of applied doseStratum corneum of human breast skin22890441
1049β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~7% of applied doseStratum corneum of human breast skin22890441
1050β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~3% of applied doseStratum corneum of human breast skin22890441
1051β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC2% of applied doseStratum corneum of human breast skin22890441
1052β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~11% of applied doseEpidermis of human breast skin22890441
1053β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~9% of applied doseEpidermis of human breast skin22890441
1054β-Ala-HN-acetyl- L -carnosineAntioxidantFranz diffusion cell, HPLC~3% of applied doseEpidermis of human breast skin22890441